[EATG Global HIV News daily digest] Digest #193-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -



Latest Headlines




  GlaxoSmithKline promises to reduce prices of its HIV treatment drugs for Russia in 2010
  Access to treatment Sunday 08 November 2009
					
  
GlaxoSmithKline, the pharmaceutical company which earlier rejected
Russia’s requests to cut prices for HIV medications, announced its
readiness to reduce the prices by up to 40% in its letter to the head
of the Russian Federal Service on Consumer Rights Protection and Human
Well-being Gennady Onischenko. 
  SOURCE:
SPDFund




  Valeant Pharmaceuticals highlights taribavirin Phase IIb end of study data presentation at AASLD Annual Meeting
  Hepatitis Sunday 08 November 2009
					
  
It is believed that taribavirin may present an alternative therapy to
ribavirin for the treatment of hepatitis C by delivering similar
efficacy to ribavirin but with significantly less anemia.
  SOURCE:
Valeant Pharmaceuticals




  EU seizure of another Indian consignment triggers angry debate at WTO meet
  EU Policy Sunday 08 November 2009
					
  
Another consignment of Indian generic drug has landed in trouble in
European airport notwithstanding the international concern and
persistent diplomatic attempts in the past against such seizures.
  SOURCE:
Pharmabiz.com




  AASLD: HCV response linked strongly to gene variant
  Hepatitis Sunday 08 November 2009
					
  
Additional analysis has confirmed that a polymorphism in an
interferon-related gene is strongly associated with responses to
standard treatments for hepatitis C virus infection.
  SOURCE:
MedPage Today




  FDA
approves labeling update for REYATAZ® capsules to include 96-week data
for previously untreated HIV-1 infected adult patients 
  Treatment Sunday 08 November 2009
					
  
The CASTLE Study assessed a once-daily REYATAZ/ritonavir-based regimen
versus a twice-daily lopinavir/ritonavir-based regimen in previously
untreated adult patients infected with HIV-1.
  SOURCE:
Bristol-Myers Squibb Company




  Report projects global HIV/AIDS pandemic could cost $35 billion annually by 2031
  World Policy Sunday 08 November 2009
					
  
A recent report by the AIDS 2031 project warns that funding to fight
HIV and AIDS in developing countries could reach $35 billion annually
by 2031 if governments continue with current approaches.
  SOURCE:
The AIDS Beacon




  New findings may lead to novel therapeutic approaches for HIV and prostate cancer
  Basic Science Sunday 08 November 2009
					
  
"This is an entirely new approach to treating these two diseases, which
are extraordinarily important in terms of their impact on human
health." 
  SOURCE:
The Medical News




  ART as part of HIV prevention strategy supported by WHO
  Prevention Sunday 08 November 2009
					
  
AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said.
  SOURCE:
The Medical News




  Rochester researchers explore possible HIV-associated hearing loss
  Treatment Sunday 08 November 2009
					
  
“If there is hearing impairment, it could be related to the disease
itself; it might be related to infections that our patients with HIV
are prone to getting; or it might be related to the medications used to
treat the disease.”
  SOURCE:
AIDSmeds.com


----------------------------------------------------

DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.



  





      
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091108/77da9002/attachment-0001.html>